Principal Investigator
Charles Mitchell
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250102
Clinical Trial Summary
A Phase 3b, open label, randomized, standard-ofcare
control arm, multicenter, superiority study
evaluating the efficacy, safety and tolerability of
injectable CAB LA + RPV LA in viremic
participants living with HIV-1 (CROWN)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Nicolette Gomez
Phone Number
+1 (305) 2434447
Email
n.gomez8@umiami.edu